Sign up to save your podcasts
Or
Share Matt Callahan, Founder & Executive Director of Botanix Pharmaceuticals
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Matt Callahan, Founder & Executive Director of Botanix Pharmaceuticals
For this brand new episode of Finding the Front we are so fortunate to have biotech and life sciences veteran Matt Callahan on the show. Matt is a Philadelphia based, Australian born life sciences entrepreneur, with a track record of building and exiting numerous life sciences companies in pain, oncology, dermatology, cell therapies, animal health and regenerative medicine.
He starts the show off on the front foot answering the question of Donald Trumps impact going forward on the US Biotech and Life Science sector showcasing his thoughts for aspiring investors.
Matt has accumulated 25 years legal, life sciences, IP and investment management experience and is founder and executive director of ASX listed Botanix Pharmaceuticals, co-founder and director of Respirion Pharmaceuticals Pty Ltd and was also a co-founder of life science companies Dimerix Bioscience Ltd, Mirata Pharmaceuticals LLC and Orthocell Ltd, as well as the Bill Gates backed climate tech company, Rumin8 Pty Ltd.
Matt is such a great communicator and provides some deep insights into being an entrepreneur, the world of life sciences, FDA approval, the phases of a company and distribution. This really is a captivating chat.
To request a Euroz Hartleys team member to contact you or if you have some feedback on the podcast please click here
Please follow us and stay up to date with Euroz Hartleys on LinkedIn
To be added to the podcast “new release” email distribution list please click here
View all episodes
By Euroz HartleysFor this brand new episode of Finding the Front we are so fortunate to have biotech and life sciences veteran Matt Callahan on the show. Matt is a Philadelphia based, Australian born life sciences entrepreneur, with a track record of building and exiting numerous life sciences companies in pain, oncology, dermatology, cell therapies, animal health and regenerative medicine.
He starts the show off on the front foot answering the question of Donald Trumps impact going forward on the US Biotech and Life Science sector showcasing his thoughts for aspiring investors.
Matt has accumulated 25 years legal, life sciences, IP and investment management experience and is founder and executive director of ASX listed Botanix Pharmaceuticals, co-founder and director of Respirion Pharmaceuticals Pty Ltd and was also a co-founder of life science companies Dimerix Bioscience Ltd, Mirata Pharmaceuticals LLC and Orthocell Ltd, as well as the Bill Gates backed climate tech company, Rumin8 Pty Ltd.
Matt is such a great communicator and provides some deep insights into being an entrepreneur, the world of life sciences, FDA approval, the phases of a company and distribution. This really is a captivating chat.
To request a Euroz Hartleys team member to contact you or if you have some feedback on the podcast please click here
Please follow us and stay up to date with Euroz Hartleys on LinkedIn
To be added to the podcast “new release” email distribution list please click here
More shows like Finding the Front
View all
The Joe Rogan Experience
229,734 Listeners
Making Sense with Sam Harris
26,344 Listeners
The Mentor with Mark Bouris
46 Listeners
Conversations
846 Listeners
NAB Morning Call
18 Listeners
Life and Crimes with Andrew Rule
486 Listeners
Money of Mine
27 Listeners
All-In with Chamath, Jason, Sacks & Friedberg
9,927 Listeners
The Rest Is History
14,589 Listeners
The Money Café with Alan Kohler
30 Listeners
How I Made It
19 Listeners
Chanticleer
22 Listeners
The Fin
17 Listeners
The Rest Is Politics: US
2,251 Listeners